Zhun Wei, Kezhou Xia, Di Zheng, Changtian Gong, & Weichun Guo. (2023). RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway. BMC.
Chicago Style (17th ed.) CitationZhun Wei, Kezhou Xia, Di Zheng, Changtian Gong, and Weichun Guo. RILP Inhibits Tumor Progression in Osteosarcoma via Grb10-mediated Inhibition of the PI3K/AKT/mTOR Pathway. BMC, 2023.
MLA (9th ed.) CitationZhun Wei, et al. RILP Inhibits Tumor Progression in Osteosarcoma via Grb10-mediated Inhibition of the PI3K/AKT/mTOR Pathway. BMC, 2023.
Warning: These citations may not always be 100% accurate.